
About this episode
Greg Stein, Vice President, M&A and Strategy at Xerox (NASDAQ: XRX)
For public equity analysts, M&A is nothing new. One of their main jobs is to conduct financial analyses of companies and other potential investments. However, M&A execution is another story.
In this episode of the M&A Science Podcast, Greg Stein, Vice President of M&A and Ventures at Xerox, shares his experience as a public equity analyst and how his role evolved to executing M&A.
____________________________________________________________________________
This episode is sponsored by FirmRoom, the fastest virtual data room used to get deals done. Leave the pay-per-page world behind by going to https://firmroom.com/
Episode Timestamps
00:00 Intro
06:42 From public equity analyst to doing deals
07:32 Executing M&A against the strategy
10:49 Assessing M&A processes of companies
13:58 Trends between announcement of a deal and stock price
15:50 Transition from PE analyst role into corp dev
17:48 How to evaluate a business
19:26 Walking away from a deal
21:11 Integration aspects
24:09 Potential pitfalls in a deal
25:25 Prioritizing diligence
26:54 Guiding principles
28:08 Deal timeline and who gets involved
30:52 People overlap
32:25 Preliminary diligence as a Public Equity Analyst
35:59 Tips for negotiations
38:09 Advice for people transitioning from public equity role to M&A
40:10 Craziest thing in M&A
Get every episode summarized
Each time M&A Science publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from M&A Science

Cultural Fit Over EBITDA: How Salas O'Brien Built a 30-Merger Program Without a...
M&A Science

Cross-Border M&A: How to Do Deals in Italy with Mauro Sambati and Donato Romano
M&A Science

Four Questions That Defined a $1 Billion Deal with Robert Lovegrove
M&A Science

Stop Falling in Love with the Deal: Guardrails for High-Volume Acquisitions with...
M&A Science